Back to trial details

Intake questionnaire

A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)

Applying to M D Anderson Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 5 answered

1. Are you 18 years old or older?
2. Do you identify as female?
3. Have you been diagnosed with Breast Cancer?
4. Are you currently pregnant or breastfeeding?
5. Are you able to travel to Houston for study visits?